from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3613c/-

LFCtreatmentdescriptionclass of inhibitor

-0.396

Amikacinug/mL Amikacintranslation

-0.170

Cap5-10ug/mL Capreomycintranslation

-0.214

Rox10-50 ug/mL Roxithromycintranslation

1.280

SM2-5 ug/mL Streptomycintranslation

-0.377

Tet5-10 ug/mL Tetracyclinetranslation

0.406

Rif0.2-5ug/mL Rifampicintranscription

0.425

Rifp0.1-0.5ug/mL Rifapentinetranscription

3.643

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.407

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.361

CPZ10-50 ug/mL Chlorpromazinerespiration

0.700

Clofazimine10-13 ug/mL Clofaziminerespiration

0.304

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.081

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.708

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.917

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.349

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.787

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.429

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.362

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.354

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.485

KCN5-20 ug/mL Potassium cyaniderespiration

1.153

NaN30.2-2 mM Sodium aziderespiration

0.252

Nigericin50 uM Nigericinrespiration

0.021

TRC10-150 ug/mL Triclosanrespiration

-0.722

TRZ10-25 ug/mL Thioridazinerespiration

-0.813

Valinomycin0.5-10 uM Valinomycinrespiration

1.706

ZnSO42 mM ZnSO4respiration

-1.624

menadione6-10 ug/mL Menadionerespiration

0.229

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.261

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.016

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.160

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

2.636

NRP_1Non-replicating persistence stage 1dosRassociated

0.612

Amp0.2mg/mL AmpicillincellWall

-0.190

Cephalexin20-100 ug/mL CephalexincellWall

-0.438

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.292

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.445

EMB10-20 ug/mL EthambutolcellWall

-0.638

Eta12-40 ug/mL EthionamidecellWall

-0.923

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.686

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.617

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.055

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.381

BZA0.12 mg/mL BenzamidearomaticAmides

-0.558

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.609

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.323

H2O24 mM hydrogen peroxideDNAdamaging

0.386

Levo10 ug/mL LevofloxacinDNAdamaging

0.140

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.582

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.124

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.129

UVUV-irradiationDNAdamaging

0.863

ARP41-4 ug/mL Antitubercular compound ARP4?

0.443

Antimycin12.5-50 ug/mL Antimycin A?

-0.303

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.109

PA_110-50 ug/mL Antitubercular compound PA-1?

0.023

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.632

PA8240.2-2 ug/mL PA-824?

-1.144

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.467

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.583

Verapamil50 uM Verapamil?

0.159

mercaptoethanol2 mM 2-Mercaptoethanol?

0.169

methoxatin10-20 ug/mL Methoxatin?